Individuals living with Alzheimer’s dementia often experience cognitive, behavioral, and functional impairments resulting in the need for professional or non-professional care partner support. Read More
The Agitation in Alzheimer’s Screener for Caregivers (AASC™) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed… Read More
Listen to Amica Simmons-Yon, PharmD, PhD and Aneta Fornal, PharmD as they spill the tea on Agitation in Alzheimer’s Dementia with special guest, Marc Agronin, MD. During this episode, Dr.… Read More
Among respondents currently managing patients with AAD, 91% of respondents believed that there is stigma associated with AAD, 93% endorsed that stigma associated with AAD negatively impacts patient care, and… Read More
Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers… Read More
In this interview, Dennis Sholler sits down with Drs. Marc Agronin and Ara Khachaturian to tackle common questions about agitation associated with Alzheimer’s dementia. Read More
The Agitation in Alzheimer’s Screener for Caregivers (AASCTM) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed… Read More
There’s a need for an easy, pragmatic screener to facilitate caregiver recognition of AAD and HCP discussions. AASC™, a brief screening tool based on the International Psychogeriatric Association (IPA) consensus… Read More